+

WO2008009860A3 - Utilisation de composés antagonistes des canaux calcium pour dépigmenter la peau - Google Patents

Utilisation de composés antagonistes des canaux calcium pour dépigmenter la peau Download PDF

Info

Publication number
WO2008009860A3
WO2008009860A3 PCT/FR2007/051687 FR2007051687W WO2008009860A3 WO 2008009860 A3 WO2008009860 A3 WO 2008009860A3 FR 2007051687 W FR2007051687 W FR 2007051687W WO 2008009860 A3 WO2008009860 A3 WO 2008009860A3
Authority
WO
WIPO (PCT)
Prior art keywords
depigmenting
skin
calcium channel
channel antagonist
antagonist compounds
Prior art date
Application number
PCT/FR2007/051687
Other languages
English (en)
Other versions
WO2008009860A2 (fr
Inventor
Lionel Breton
Original Assignee
Oreal
Lionel Breton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0653062A external-priority patent/FR2903901B1/fr
Application filed by Oreal, Lionel Breton filed Critical Oreal
Publication of WO2008009860A2 publication Critical patent/WO2008009860A2/fr
Publication of WO2008009860A3 publication Critical patent/WO2008009860A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention se rapporte à l'utilisation d'au moins un composé antagoniste des canaux calcium pour dépigmenter et/ou blanchir la peau.
PCT/FR2007/051687 2006-07-21 2007-07-18 Utilisation de composés antagonistes des canaux calcium pour dépigmenter la peau WO2008009860A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0653062 2006-07-21
FR0653062A FR2903901B1 (fr) 2006-07-21 2006-07-21 Utilisation de composes antagonistes des canaux calcium pour depigmenter la peau.
US83380606P 2006-07-28 2006-07-28
US60/833,806 2006-07-28

Publications (2)

Publication Number Publication Date
WO2008009860A2 WO2008009860A2 (fr) 2008-01-24
WO2008009860A3 true WO2008009860A3 (fr) 2009-06-18

Family

ID=38957137

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2007/051687 WO2008009860A2 (fr) 2006-07-21 2007-07-18 Utilisation de composés antagonistes des canaux calcium pour dépigmenter la peau

Country Status (1)

Country Link
WO (1) WO2008009860A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2936149B1 (fr) 2008-09-23 2013-01-04 Francois Fauran Utilisation de l'alverine dans le traitement des affections cutanees
JP5377927B2 (ja) * 2008-10-29 2013-12-25 株式会社ファンケル 美白剤
JP5823696B2 (ja) * 2008-12-22 2015-11-25 ポーラ化成工業株式会社 メラニン産生抑制剤
CA2748375C (fr) 2009-01-16 2017-08-01 Neocutis Sa Compositions de sequestration du calcium et procedes de traitement des troubles et des affections de la pigmentation de la peau
US8476251B2 (en) 2010-07-29 2013-07-02 Conopco, Inc. Skin care compositions comprising substituted diamines
US8293218B2 (en) 2010-07-29 2012-10-23 Conopco, Inc. Skin care compositions comprising substituted monoamines
EP3634582A1 (fr) * 2017-06-08 2020-04-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Procédés et compositions pour le traitement de troubles de l'hyperpigmentation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1003002A6 (fr) * 1989-03-21 1991-10-22 Coppe Jan Composition a mettre en oeuvre pour le traitement de la calvitie, et procedes faisant usage de celle-ci.
EP1053745A1 (fr) * 1999-05-18 2000-11-22 L'oreal Utilisation d'au moins un inhibiteur d'au moins un canal calcique dans le traitement des rides
WO2002049603A1 (fr) * 2000-12-20 2002-06-27 Lg Household & Health Care Ltd. Compositions servant a prevenir et a limiter les rides
KR20060052748A (ko) * 2006-04-21 2006-05-19 주식회사 그린원일 신규한 히드록시아닐린 유도체의 염을 포함하는 화장품조성물

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1003002A6 (fr) * 1989-03-21 1991-10-22 Coppe Jan Composition a mettre en oeuvre pour le traitement de la calvitie, et procedes faisant usage de celle-ci.
EP1053745A1 (fr) * 1999-05-18 2000-11-22 L'oreal Utilisation d'au moins un inhibiteur d'au moins un canal calcique dans le traitement des rides
WO2002049603A1 (fr) * 2000-12-20 2002-06-27 Lg Household & Health Care Ltd. Compositions servant a prevenir et a limiter les rides
KR20060052748A (ko) * 2006-04-21 2006-05-19 주식회사 그린원일 신규한 히드록시아닐린 유도체의 염을 포함하는 화장품조성물

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JO Y K ET AL: "Whitening cosmetic composition comprising hydroxyaniline derivative salts which inhibit activity of tyrosinase and melanine formation without side-effects", WPI / THOMSON,, 1 January 1900 (1900-01-01), XP002431384 *

Also Published As

Publication number Publication date
WO2008009860A2 (fr) 2008-01-24

Similar Documents

Publication Publication Date Title
GB2426023B (en) Structured composite compositions for treatment of subterranenan wells
WO2008011560A3 (fr) Inhibiteurs de la rho kinase à base de benzothiophène
WO2008112199A8 (fr) Procédé d'inhibition de la topoisomérase ii
IL197668A0 (en) Rna antagonist compounds for the modulation of pcsk9
IL183938A0 (en) Amino - imidazolones for the inhibition of ?? - becretase
IL184303A0 (en) Amino-pyridines as inhibitors of ??-secretase
WO2008051416A3 (fr) Procede permettant de traiter des infections
IL195341A0 (en) Methods and materials for making simvastatin and related compounds
ZA200807862B (en) Azolopyrimidines as inhibitors of cannabinoid 1 activity
WO2007150015A3 (fr) Procédé de traitement
HK1105859A1 (en) Composition for prevention or alleviation of pigmentation
WO2006128143A3 (fr) Composes a base d'hydantoine
WO2009009041A3 (fr) Compositions et procédés permettant de moduler une cascade de kinases
PL1912972T3 (pl) Podstawione związki imidazolowe jako inhibitory KSP
IL213694A0 (en) Melanin production inhibitor compounds and compositions comprising the same
SI1912640T1 (sl) Uporaba inhibitorja hdac panobinostata za zdravljenje mieloma
IL190730A0 (en) Potassium channel inhibitors
WO2008009860A3 (fr) Utilisation de composés antagonistes des canaux calcium pour dépigmenter la peau
PL1963280T3 (pl) Pochodne 2-fenyloetyloaminowe jako modulatory kanału wapniowego i/lub sodowego
WO2007050348A3 (fr) Inhibiteurs du canal potassique
GB0912562D0 (en) LXR-antagonists for the prevention, reduction or inhibition of scarring
AU2006260779A8 (en) Lavatory block composition
GB0909297D0 (en) Composition for the treatment of skin conditions
WO2006134499A3 (fr) Derives de 2-(1h-indolylsulfanyl)-aryl amine
EP1855674A4 (fr) Composition destinee a l'inhibition de cathepsine k

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07823606

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载